In the rapidly evolving world of medical weight loss, two names dominate the conversation: Wegovy (semaglutide) and Mounjaro (tirzepatide). While both are game-changers for obesity management and type 2 diabetes, they are not identical.
For patients trying to decide between the two, understanding the science, results, and safety profiles is crucial. This guide breaks down the key differences to help you have an informed discussion with your doctor.
How Do They Work?
Both medications belong to a class of drugs that mimic natural hormones in your body to control blood sugar and appetite. However, their mechanisms differ slightly.
- Wegovy (Semaglutide): This is a GLP-1 receptor agonist. It mimics one hormone (glucagon-like peptide-1) that targets the brain to reduce appetite and slows down stomach emptying, making you feel full longer.
- Mounjaro (Tirzepatide): This is the first-in-class dual agonist. It mimics two hormones: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This “synergistic” effect is believed to be the reason behind its higher potency.
Which One Burns More Fat?
When strictly comparing weight loss percentages in clinical trials, Mounjaro currently holds the edge.
- Wegovy Results: Clinical trials (STEP program) showed an average body weight reduction of approximately 15% over 68 weeks.
- Mounjaro Results: Trials (SURMOUNT program) demonstrated an average reduction of up to 21-22.5% at the highest dose over 72 weeks.
The Verdict: While both offer significant results far exceeding diet and exercise alone, Mounjaro (tirzepatide) statistically provides greater weight reduction.
FDA Indications & Approval Status
It is important to use the correct medication for your specific condition.
- Wegovy: FDA-approved specifically for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with comorbidities. It is also approved to reduce the risk of heart attack and stroke in patients with cardiovascular disease.
- Mounjaro: FDA-approved for Type 2 Diabetes. However, its active ingredient (tirzepatide) is FDA-approved for weight loss.
What to Expect
Both medications have a similar safety profile, with gastrointestinal issues being the most common complaint. These typically improve as your body adjusts.
- Common Side Effects: Nausea, diarrhea, vomiting, constipation, and stomach pain.
- Serious Risks (Rare): Pancreatitis, gallbladder problems, and potential thyroid C-cell tumors (observed in rodents).
- Muscle Loss: Rapid weight loss can lead to muscle wasting (sarcopenia). It is vital to maintain high protein intake and resistance training while on these medications.
Comparison Summary
| Feature | Wegovy (Semaglutide) | Mounjaro (Tirzepatide) |
| Drug Class | Single Agonist (GLP-1) | Dual Agonist (GLP-1 + GIP) |
| Weight Loss | ~15% | ~21% |
| Best For | Weight loss + Heart Health | Maximum Weight Loss + Diabetes Control |
| Administration | Weekly Injection | Weekly Injection |
Aesthetic Concern: “Ozempic Face”
In Thailand, maintaining facial volume is a key aesthetic goal. Rapid weight loss from any of these drugs can lead to “Ozempic Face”—a gaunt, hollowed look caused by the loss of facial fat pads.
- Prevention: We recommend a “Slow and Steady” titration approach. Do not rush to the highest dose.
- Treatment: Patients concerned about facial volume should discuss combining their weight loss program with Biostimulators (like Sculptra) or Fillers to maintain a youthful structure while slimming down the body.
Safety & Availability
- Legal Status: Both Mounjaro and Wegovy are available in trusted private hospitals and clinics in Thailand.
- Beware of Fakes: With the popularity of these drugs, “gray market” or chilled shipping online sellers have appeared. Never buy these online without a prescription. Improper storage (temperature control) renders the drug ineffective, and fake pens are a serious safety risk.
Which One Should You Choose?
1. Choose Ozempic/Wegovy if:
- You are price-sensitive (Ozempic is the most affordable entry point).
- You have a history of heart disease (Wegovy has specific heart-health benefits).
- You are comfortable with the results you are currently seeing.
2. Choose Mounjaro if:
- Weight loss is the priority: You want the most potent medication available.
- You have “stalled”: You are no longer losing weight on Semaglutide.
- Metabolic Health: You have insulin resistance or Type 2 Diabetes and need aggressive blood sugar control.
Mounjaro vs. Wegovy: The 2026 Guide for Asian Bodies & Thai Patients >> Link
Wegovy vs. Mounjaro in Thailand: The Expat’s Guide (2026) >> Link
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Weight loss injections are prescription medications that require medical supervision. Consult a healthcare provider to determine if these treatments are safe for you.
